These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23165680)

  • 1. ACP Journal Club. Review: statins decrease mortality and major CV events in adults with CKD not receiving dialysis.
    Ramesh Prasad GV
    Ann Intern Med; 2012 Nov; 157(10):JC5-4. PubMed ID: 23165680
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Review: lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD.
    Ramesh Prasad GV
    Ann Intern Med; 2012 Nov; 157(10):JC5-5. PubMed ID: 23165681
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk.
    Muñoz D; Granger CB
    Ann Intern Med; 2012 Apr; 156(8):JC4-07. PubMed ID: 22508747
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. Review: Blood pressure-lowering treatments reduce CV morbidity and mortality in patients receiving dialysis.
    Harnett J
    Ann Intern Med; 2009 Jul; 151(2):JC1-6. PubMed ID: 19620150
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Review: Statins reduce mortality and cardiovascular events in adults at risk for cardiovascular disease.
    Davidson RA; Rosenberg E
    Ann Intern Med; 2009 Oct; 151(8):JC4-14. PubMed ID: 19841451
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Use of ≥ 1 antihypertensive drug at bedtime reduced CV events more than use of all drugs in the morning in CKD.
    Sinha AD; Agarwal R
    Ann Intern Med; 2012 Jun; 156(12):JC6-8. PubMed ID: 22711109
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club: Review: Low BP targets do not reduce mortality or CV events in hypertension.
    McAlister FA
    Ann Intern Med; 2009 Nov; 151(10):JC5-6-7. PubMed ID: 19920264
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Review: Counseling and educational methods that target multiple CV risk factors do not reduce mortality in adults without CHD.
    Patel MJ; Newby LK
    Ann Intern Med; 2011 Jun; 154(12):JC6-4. PubMed ID: 21690582
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes.
    Lipscombe LL
    Ann Intern Med; 2009 Sep; 151(6):JC3-6. PubMed ID: 19755352
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club: review: varenicline for tobacco cessation does not increase CV serious adverse events.
    Krebs P; Sherman SE
    Ann Intern Med; 2012 Aug; 157(4):JC2-2. PubMed ID: 22910956
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. The Cardiovascular Health Awareness Program reduced CV hospitalizations but not mortality in older adults.
    Elley CR; Kerse N
    Ann Intern Med; 2011 Jun; 154(12):JC6-3. PubMed ID: 21690581
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Daily multivitamin supplements did not reduce risk for major CV events over > 10 years in men.
    Fairfield KM
    Ann Intern Med; 2013 Feb; 158(4):JC8. PubMed ID: 23420255
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults.
    Smith DA
    Ann Intern Med; 2012 Dec; 157(12):JC6-5. PubMed ID: 23247954
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: statins reduce pancreatitis in adults with normal or mildly elevated triglyceride levels.
    Bloomfield HE
    Ann Intern Med; 2012 Dec; 157(12):JC6-8. PubMed ID: 23247957
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Meta-analysis: lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk.
    Jain M; Rosenberg M
    Ann Intern Med; 2012 Oct; 157(8):JC4-2. PubMed ID: 23070504
    [No Abstract]   [Full Text] [Related]  

  • 16. ACP journal club. Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes.
    Grubina R; Smith SA
    Ann Intern Med; 2011 May; 154(10):JC5-02. PubMed ID: 21576520
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Androgen deprivation therapy does not increase CV mortality in prostate cancer.
    Canfield SE; Dahm P
    Ann Intern Med; 2012 Apr; 156(8):JC4-04, JC4-05. PubMed ID: 22508744
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD.
    Poirier P
    Ann Intern Med; 2009 Oct; 151(8):JC4-5. PubMed ID: 19841443
    [No Abstract]   [Full Text] [Related]  

  • 19. ACP Journal Club. Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors.
    Ann Intern Med; 2010 Jun; 152(12):JC6-9. PubMed ID: 20547903
    [No Abstract]   [Full Text] [Related]  

  • 20. ACP Journal Club. Review: Statins are effective for prevention of cardiovascular events in patients without coronary heart disease.
    McAlister FA
    Ann Intern Med; 2009 Apr; 150(8):JC4-5. PubMed ID: 19391211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.